Measles virus continues to be a major killer of children, claiming roughly one million lives a year1. Measles virus infection causes profound immunosuppression, which makes measles patients susceptible to secondary infections accounting for high morbidity and mortality2. The Edmonston strain of measles virus, and vaccine strains derived from it, use as a cellular receptor human CD46 (refs 3, 4), which is expressed on all nucleated cells; however, most clinical isolates of measles virus cannot use CD46 as a receptor5. Here we show that human SLAM (signalling lymphocyte-activation molecule; also known as CDw150), a recently discovered membrane glycoprotein expressed on some T and B cells6, is a cellular receptor for measles virus, including the Edmonston strain. Transfection with a human SLAM complementary DNA enables non-susceptible cell lines to bind measles virus, support measles virus replication and develop cytopathic effects. The distribution of SLAM on various cell lines is consistent with their susceptibility to clinical isolates of measles virus. The identification of SLAM as a receptor for measles virus opens the way to a better understanding of the pathogenesis of measles virus infection, especially the immunosuppression induced by measles virus.
Subscribe to Journal
Get full journal access for 1 year
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Oldstone, M. B. A. Viruses, Plagues, & History (Oxford Univ. Press, New York, 1998).
Griffin, D. E. & Bellini, W. J. in Fields Virology (eds. Fields, B. N. et al.) 1267–1312 (Lippincott-Raven, Philadelphia, 1996).
Naniche, D. et al. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 67, 6025–6032 (1993).
Dorig, R. E., Marcil, A., Chopra, A. & Richardson, C. D. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75, 295–305 ( 1993).
Buckland, R. & Wild, T. F. Is CD46 the receptor for measles virus? Virus Res. 48, 1– 9 (1997).
Cocks, B. G. et al. A novel receptor involved in T-cell activation. Nature 376, 260–263 ( 1995).
Kobune, F., Sakata, H. & Sugiura, A. Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J. Virol. 64, 700–705 (1990).
Kobune, F. et al. Nonhuman primate models of measles. Lab. Anim. Sci. 46, 315–320 ( 1996).
Schneider-Schaulies, J. et al. Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains. Proc. Natl Acad. Sci. USA 92, 3943–3947 ( 1995).
Schneider-Schaulies, J., Dunster, L. M., Kobune, F., Rima, B. & Ter Meulen, V. Differential downregulation of CD46 by measles virus strains. J. Virol. 69, 7257–7259 (1995).
Lecouturier, V. et al. Identification of two amino acids in the hemagglutinin glycoprotein of measles virus (MV) that govern hemadsorption, HeLa cell fusion, and CD46 downregulation: phenotypic markers that differentiate vaccine and wild-type MV strains. J. Virol. 70, 4200– 4204 (1996).
Hsu, E. C. et al. A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells. J. Virol. 72, 2905– 2916 (1998).
Tanaka, K., Xie, M. & Yanagi, Y. The hemagglutinin of recent measles virus isolates induces cell fusion in a marmoset cell line, but not in other CD46-positive human and monkey cell lines, when expressed together with the F protein. Arch. Virol. 143, 213–225 ( 1998).
Tatsuo, H. et al. Virus entry is a major determinant of cell tropism of Edmonston and wild-type strains of measles virus as revealed by vesicular stomatitis virus pseudotypes bearing their envelope proteins. J. Virol. 74, 4139–4145 (2000).
Takada, A. et al. A system for functional analysis of Ebola virus glycoprotein. Proc. Natl Acad. Sci. USA 94, 14764– 14769 (1997).
Niwa, H., Yamamura, K. & Miyazaki, J. Efficient selection for high-expression transfectants by a novel eukaryotic vector. Gene 108, 193–200 (1991).
Sidorenko, S. P. & Clark, E. A. Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes. J. Immunol. 151, 4614– 4624 (1993).
Manchester, M. et al. Clinical isolates of measles virus use CD46 as a cellular receptor. J. Virol. 74, 3967– 3974 (2000).
Huber, M. et al. Measles virus phosphoprotein retains the nucleocapsid protein in the cytoplasm. Virology 185, 299– 308 (1991).
Aversa, G. et al. SLAM and its role in T cell activation and Th cell responses. Immunol. Cell Biol. 75, 202– 205 (1997).
Aversa, G., Chang, C.-C., Carballido, J. M., Cocks, B. G. & de Vries, J. E. Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gamma production. J. Immunol. 158, 4036–4044 (1997).
McChesney, M. B. et al. Experimental measles. I. Pathogenesis in the normal and the immunized host. Virology 233, 74– 84 (1997).
Liszewski, M. K., Post, T. W. & Atkinson, J. P. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu. Rev. Immunol. 9, 431–455 (1991).
Yanagi, Y., Cubitt, B. A. & Oldstone, M. B. A. Measles virus inhibits mitogen-induced T cell proliferation but does not directly perturb the T cell activation process inside the cell. Virology 187, 280– 289 (1992).
Schlender, J. et al. Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro. Proc. Natl Acad. Sci. USA 93, 13194– 13199 (1996).
Punnonen, J. et al. Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes. J. Exp. Med. 185, 993 –1004 (1997).
Sayos, J. et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395, 462–469 (1998).
Mikhalap, S. V. et al. CDw150 associates with Src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis. J. Immunol. 162, 5719–5727 ( 1999).
Griffin, D. E. & Ward, B. J. Differential CD4 T cell activation in measles. J. Infect. Dis. 168, 275–281 (1993).
McFarlin, D. E., Bellini, W. J., Mingioli, E. S., Behar, T. N. & Trudgett, A. Monospecific antibody to the haemagglutinin of measles virus. J. Gen. Virol. 48, 425 –429 (1980).
We thank M. A. Whitt for allowing us to use the VSVΔG*-GFP system; F. Kobune and M. Manchester for providing MV strains; T. Aoki for providing throat swabs from measles patients; and Y. Matsuura, K. Ishihara and members of our laboratory for helpful discussions. This work was supported by grants from the Ministry of Education, Science and Culture of Japan and from the Program for Promotion of Fundamental Studies in Health Sciences of the Organization for Drug ADR Relief, R&D Promotion and Product Review of Japan.
About this article
Cite this article
Tatsuo, H., Ono, N., Tanaka, K. et al. SLAM (CDw150) is a cellular receptor for measles virus. Nature 406, 893–897 (2000). https://doi.org/10.1038/35022579
Receptor-mediated cell entry of paramyxoviruses: Mechanisms, and consequences for tropism and pathogenesis
Journal of Biological Chemistry (2020)
Aedes aegypti lachesin protein binds to the domain III of envelop protein of Dengue virus‐2 and inhibits viral replication
Cellular Microbiology (2020)
Non-transmissible MV Vector with Segmented RNA Genome Establishes Different Types of iPSCs from Hematopoietic Cells
Molecular Therapy (2020)
Current Opinion in Virology (2020)
Development of an Enzyme-Linked Immunosorbent Assay Based on CD150/SLAM for the Detection of Peste des Petits Ruminant Virus
Frontiers in Veterinary Science (2020)